GlassScriptPhysician profile
Cole Oswald
NPI 1346941994
$677.91
in general payments reported to CMS, 2019-2025
7 companies · $578 in 2025
The $578 reported for 2025 was more than what 78% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $99.59 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $390 · Travel and Lodging: $252 · Education: $36.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $390.00 |
| Travel and Lodging | $251.91 |
| Education | $36.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $550.52 | 2024-2025 | General - Therapies, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $36.00 | 2024 | |
| Heartflow, INC. | $23.31 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $21.55 | 2025 | Camzyos |
| Itamar Medical INC | $17.99 | 2024 | Watchpatone |
| Angiodynamics, INC. | $14.29 | 2025 | Alphavac |
| Novo Nordisk INC | $14.25 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cole Oswald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.